Abilify (aripiprazole) NDC 59148-007

NDC codes

FDA NDC Directory

Product NDC (as listed)59148-007Labeler and product segments. Claims need a package NDC.

Product NDC at billing width59148-0007Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
59148-007-13	59148000713	30 TABLET in 1 BOTTLE, PLASTIC (59148-007-13)Marketed from Nov 15, 2002
59148-007-35	59148000735	100 TABLET in 1 BLISTER PACK (59148-007-35)Marketed from Nov 15, 2002
59148-007-94	59148000794	7 TABLET in 1 BLISTER PACK (59148-007-94)Marketed from Nov 15, 2002

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Abilify
Generic name (nonproprietary): aripiprazole
Active ingredients: Aripiprazole — 5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Otsuka America Pharmaceutical, Inc.
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 021436
Marketing start: Nov 15, 2002
Listing expires: Dec 31, 2026
Identifiers: Product ID 59148-007_1b189d15-798d-4bed-a93d-a543ed7abd81SPL ID 1b189d15-798d-4bed-a93d-a543ed7abd81SPL set ID c040bd1d-45b7-49f2-93ea-aed7220b30acRxCUI 349490, 349545, 349547, 349553, 352307, 352308, 352309, 352310, 402131, 404602, 602964, 615172UNII 82VFR53I78
Pharmacologic class: Atypical Antipsychotic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N459148000713 followed by a unit qualifier and the quantity

Package 59148-0007-13. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 29, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

ABILIFY (aripiprazole) Tablets are indicated for the treatment of: Schizophrenia Acute Treatment of Manic and Mixed Episodes associated with Bipolar I Disorder Adjunctive Treatment of Major Depressive Disorder Irritability Associated with Autistic Disorder Treatment of Tourette's Disorder ABILIFY is an atypical antipsychotic. ABILIFY is indicated for: Schizophrenia ( 14.1 ) Acute Treatment of Manic and Mixed Episodes associated with Bipolar I Disorder ( 14.2 ) Adjunctive Treatment of Major Depressive Disorder ( 14.3 ) Irritability Associated with Autistic Disorder ( 14.4 ) Treatment of Tourette's Disorder ( 14.5 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 021436

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 021436
Product	Strength	Form · route	Labeler	Product NDC
Abilifyaripiprazole	Aripiprazole 2 mg/1	TabletOral	Otsuka America Pharmaceutical, Inc.	59148-006
Abilifyaripiprazole	Aripiprazole 20 mg/1	TabletOral	Otsuka America Pharmaceutical, Inc.	59148-010
Abilifyaripiprazole	Aripiprazole 10 mg/1	TabletOral	Otsuka America Pharmaceutical, Inc.	59148-008
Abilifyaripiprazole	Aripiprazole 15 mg/1	TabletOral	Otsuka America Pharmaceutical, Inc.	59148-009
Abilifyaripiprazole	Aripiprazole 30 mg/1	TabletOral	Otsuka America Pharmaceutical, Inc.	59148-011